Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Drugs Made In America Acquisition II Corp.

DMIIR Technical Analysis Summary (NASDAQ)

Analyze DMIIR on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

DMIIR●NASDAQ
Financial ServicesFinancial - Conglomerates
$0.05
$0.005(8.73%)
U.S. Market opens in 42h 29m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

DMIIR Technical Analysis Summary (NASDAQ)

Drugs Made In America Acquisition II Corp. (NASDAQ: DMIIR) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.

Overall Sentiment:Neutral
Momentum:Bearish to Weak (RSI: 39.50)
Trend Strength:Weak (ADX: 16.11)
Volatility:High (ATR: 0.01)
Support/Resistance:$0.04 – $0.09 (Bollinger Bands)

Technical conditions suggest Drugs Made In America Acquisition II Corp. on the NASDAQ is awaiting a decisive move. Overall, Drugs Made In America Acquisition II Corp. remains neutral, with indicators showing mixed momentum.

Momentum Indicators

RSI (14): 39.50

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 6.11

Bullish
Oversold zone signals rebound potential.

Williams %R: -99.67

Bullish
Oversold zone suggests rebound potential.

Rate of Change (ROC): -26.27

Strongly Bearish
Sharp downside momentum.

Takeaway:Drugs Made In America Acquisition II Corp. shows strong bearish momentum, signaling downside pressure.

Trend & Volatility

MACD: -0.01

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 16.11

Weak
Weak trend, market trading sideways.

ATR (14): 0.01

Low
Low volatility, stable price action.

CCI (14): -88.49

Bearish
Bearish, momentum remains under pressure.

Takeaway:Drugs Made In America Acquisition II Corp. shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$0.09
Middle Band (SMA 20)
$0.06
Lower Band
$0.04
Current Position
Within Bands

Takeaway:Drugs Made In America Acquisition II Corp. trades closer to support, showing weaker momentum within bands.

Keltner Channels
Upper Channel
$0.09
Middle Line (EMA 20)
$0.06
Lower Channel
$0.04
Squeeze Status
No Squeeze

Takeaway:Drugs Made In America Acquisition II Corp. trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume-632.11K
Money Flow Index21.16Bearish, selling pressure outweighs inflows.
Relative Vigor Index19.48Bearish, price momentum favors sellers.

Overall Takeaway:DMIIR shows bearish money flow, with sellers dominating volume and vigor.

Technical Trading Signals Summary
Based on the current technical analysis of Drugs Made In America Acquisition II Corp. (NASDAQ: DMIIR), here are the key trading signals and recommendations:

Bullish Signals

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Technical indicators for Drugs Made In America Acquisition II Corp. are mixed, suggesting a Hold or wait-and-see approach.

(NASDAQ: DMIIR) Technical Analysis FAQ